← Explore

Transcranial focused ultrasound stimulation of cortical and thalamic somatosensory areas in human

Hyun-Chul Kim, Wonhye Lee, Daniel S. Weisholtz, Seung-Schik Yoo

PLOS ONE 2023, 18, e0288654 · 10.1371/journal.pone.0288654

human healthyhealthyeeg megfmri

Abstract

The effects of transcranial focused ultrasound (FUS) stimulation of the primary somatosensory cortex and its thalamic projection (i.e., ventral posterolateral nucleus) on the generation of electroencephalographic (EEG) responses were evaluated in healthy human volunteers. Stimulation of the unilateral somatosensory circuits corresponding to the non-dominant hand generated EEG evoked potentials across all participants; however, not all perceived stimulation-mediated tactile sensations of the hand. These FUS-evoked EEG potentials (FEP) were observed from both brain hemispheres and shared similarities with somatosensory evoked potentials (SSEP) from median nerve stimulation. Use of a 0.5 ms pulse duration (PD) sonication given at 70% duty cycle, compared to the use of 1 and 2 ms PD, elicited more distinctive FEP peak features from the hemisphere ipsilateral to sonication. Although several participants reported hearing tones associated with FUS stimulation, the observed FEP were not likely to be confounded by the auditory sensation based on a separate measurement of auditory evoked potentials (AEP) to tonal stimulation (mimicking the same repetition frequency as the FUS stimulation). Off-line changes in resting-state functional connectivity (FC) associated with thalamic stimulation revealed that the FUS stimulation enhanced connectivity in a network of sensorimotor and sensory integration areas, which lasted for at least more than an hour. Clinical neurological evaluations, EEG, and neuroanatomical MRI did not reveal any adverse or unintended effects of sonication, attesting its safety. These results suggest that FUS stimulation may induce long-term neuroplasticity in humans, indicating its neurotherapeutic potential for various neurological and neuropsychiatric conditions.

Abstract via europepmc.

Specieshuman
Subjects8 participants
Sessions per subject2
Randomisednot reported
Blindingsingle
Sham / controlinactive transducer
Auditory controlpost hoc check
Readout timingboth
Anaesthesianot applicable
Readoutseeg meg, fmriFUS-evoked EEG potentials (FEP) and reference somatosensory evoked potentials (SSEP) from median nerve stimulation; resting-state fMRI functional connectivity (rsFC); separate auditory evoked potential (AEP) measurement in a different participant group; clinical neurological evaluation and neuroanatomical MRI for safety
Direction of effectexcitatoryFUS to S1 and to VPL each generated distinct EEG evoked potentials (FEP) similar to somatosensory evoked potentials, with the 0.5 ms pulse-duration condition producing the most distinctive ipsilateral peaks; resting-state fMRI showed increased functional connectivity between sonicated regions and sensorimotor/associative networks lasting at least ~1 hour post-VPL stimulation.
Adverse eventsnone observedNo cavitation events were detected; no participant reported discomfort during or after sonication; repeated neurological evaluations, EEG and neuroanatomical MRI revealed no adverse or unintended effects across the study period.

Exposures

Exposure 1: Primary somatosensory cortex (S1) stimulation

Target: primary somatosensory cortex — “primary somatosensory cortex (S1, non-dominant hand representation)
Device: Ultran · Ultran Group · GPS200-D40-FL57 (D40)

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)250✓✓
Pulse duration (ms)0.5, 1, 2swept✓✓
Pulse repetition frequency (Hz)1,400, 700, 350swept✓✓
Duty cycle (%)70✓✓
Sonication duration (s)0.2✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)14.7✓✓
Free-field Ispta (W/cm²)not reported
In-situ estimatesimulationmean or range across subjects
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)4.1✓✓
In-situ Ispta (W/cm²)2.9✓✓
Protocol, in the paper’s words

Three pulse-duration (PD) conditions (0.5, 1, 2 ms), each 200 ms long, delivered at a constant 70% duty cycle (PRF adjusted per PD). Trials were administered 4 s apart; 80 trials per PD condition were given in randomized, balanced order together with a passive sham (no sonication) condition, for a session lasting ~21 min (1,280 s).

Exposure 2: Ventral posterolateral thalamic nucleus (VPL) stimulation

Target: ventral posterolateral nucleus — “ventral posterolateral nucleus (VPL), thalamic projection of the somatosensory circuit
Device: Ultran · Ultran Group · GPS200-D90-FL130 (D90)

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)250✓✓
Pulse duration (ms)0.5, 1, 2swept✓✓
Pulse repetition frequency (Hz)1,400, 700, 350swept✓✓
Duty cycle (%)70✓✓
Sonication duration (s)0.2✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)9.1✓✓
Free-field Ispta (W/cm²)not reported
In-situ estimatesimulationmean or range across subjects
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)3.4✓✓
In-situ Ispta (W/cm²)2.4✓✓
Protocol, in the paper’s words

Same pulse scheme as the S1 session (three PD conditions of 0.5, 1, 2 ms, each 200 ms long, 70% duty cycle, PRF adjusted per PD), delivered via the D90 transducer about a week after the S1 session; 80 trials per PD condition plus sham, 4 s apart, ~21 min session.

Flags from extraction

  • auditory_controlNo concurrent auditory masking was used during FUS sessions; instead, auditory evoked potentials to mimicking tones were measured in a separate group of participants after the fact to assess possible auditory confounds, which does not fit cleanly into the closed vocabulary.
  • randomisedSession order (S1 always Visit #2, VPL always Visit #3) was fixed rather than randomized across participants; within-session trial order (PD conditions and sham) was randomized and balanced, but no explicit statement of subject/group-level randomisation is given.
  • sham_typeThe 'passive sham' consisted of the transducer remaining in place with no sonication triggered during that trial, interpreted as inactive_transducer.